prednisone has been researched along with Hyperhomocysteinemia in 3 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (
| Excerpt | Relevance | Reference |
|---|---|---|
| "Homocysteine has been linked to atherosclerosis and hypertension (HT) in the general population." | 7.80 | Relationship between homocysteine levels and hypertension in systemic lupus erythematosus. ( Díaz-Chamorro, A; Jiménez-Alonso, J; Martinez-Bordonado, J; Navarrete-Navarrete, N; Olvera-Porcel, C; Sabio, JM; Vargas-Hitos, JA; Zamora-Pasadas, M, 2014) |
| "The therapeutic use of thalidomide in patients with multiple myeloma is often complicated by the development of venous thromboembolism." | 7.75 | Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. ( Claxton, D; Fink, LM; Ibrahim, S; Talamo, GP; Tricot, GJ; Zangari, M, 2009) |
| "Homocysteine has been linked to atherosclerosis and hypertension (HT) in the general population." | 3.80 | Relationship between homocysteine levels and hypertension in systemic lupus erythematosus. ( Díaz-Chamorro, A; Jiménez-Alonso, J; Martinez-Bordonado, J; Navarrete-Navarrete, N; Olvera-Porcel, C; Sabio, JM; Vargas-Hitos, JA; Zamora-Pasadas, M, 2014) |
| "The therapeutic use of thalidomide in patients with multiple myeloma is often complicated by the development of venous thromboembolism." | 3.75 | Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism. ( Claxton, D; Fink, LM; Ibrahim, S; Talamo, GP; Tricot, GJ; Zangari, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sabio, JM | 1 |
| Vargas-Hitos, JA | 1 |
| Martinez-Bordonado, J | 1 |
| Navarrete-Navarrete, N | 1 |
| Díaz-Chamorro, A | 1 |
| Olvera-Porcel, C | 1 |
| Zamora-Pasadas, M | 1 |
| Jiménez-Alonso, J | 1 |
| Talamo, GP | 1 |
| Ibrahim, S | 1 |
| Claxton, D | 1 |
| Tricot, GJ | 1 |
| Fink, LM | 1 |
| Zangari, M | 1 |
| Mahadeo, KM | 1 |
| Dhall, G | 1 |
| Panigrahy, A | 1 |
| Lastra, C | 1 |
| Ettinger, LJ | 1 |
3 other studies available for prednisone and Hyperhomocysteinemia
| Article | Year |
|---|---|
Relationship between homocysteine levels and hypertension in systemic lupus erythematosus.
Topics: Adult; Biomarkers; Blood Pressure; Body Mass Index; Case-Control Studies; Chi-Square Distribution; C | 2014 |
Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
Topics: Activated Protein C Resistance; Angiogenesis Inhibitors; Anticoagulants; Antineoplastic Combined Che | 2009 |
Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct end
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytara | 2010 |